| Cassandra Lynn Puccinelli, MD | |
|
7710 Mercy Rd Ste 3000, Omaha, NE 68124-2350 | |
| (402) 932-1999 | |
| Not Available |
| Full Name | Cassandra Lynn Puccinelli |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 7710 Mercy Rd Ste 3000, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528448958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | A168750 (California) | Secondary |
| 207Y00000X | Otolaryngology | 60867 (Minnesota) | Secondary |
| 207Y00000X | Otolaryngology | 33743 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cassandra Lynn Puccinelli, MD 7261 Mercy Rd, Omaha, NE 68124-2311 Ph: () - | Cassandra Lynn Puccinelli, MD 7710 Mercy Rd Ste 3000, Omaha, NE 68124-2350 Ph: (402) 932-1999 |
News Archive
Biotech company Pharming Group NV ("Pharming" or the "Company") has received commitment from bondholders, representing 70% of the nominal amount of the currently outstanding bonds, to accept the offer to convert the bonds as announced on September 21, 2009. Together, they exceed the threshold level of 60% which Pharming set as a minimum participation in order to execute the transaction.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the Committee for Medicinal Products for Human Use has adopted a Positive Opinion recommending marketing authorization of patisiran for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy.
Scientists are examining the feasibility of treating autistic children with neuromodulation after a new study showed social impairments can be corrected by brain stimulation.
The head of the NIH National Institute of Allergy and Infectious Diseases (NIAID), which funded "two projects that created a highly pathogenic [H5N1] flu virus mutation, has welcomed a two-month moratorium on further research while defending the value and safety of the experiments," the Financial Times reports.
› Verified 6 days ago
Rahul Mahendra Varman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 7710 Mercy Rd Ste 3000, Omaha, NE 68124 Phone: 402-932-1999 | |
Tyler Andrew Bliss, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 981225 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 316-208-9184 | |
Debora Goebel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 720 N 129th St, Omaha, NE 68154 Phone: 402-397-0670 Fax: 402-397-0713 | |
Justin Oltman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 981225 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7005 Fax: 402-559-8940 | |
Anne Kristin Maxwell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4014 Leavenworth St, Ent Clinic At Laurizten Outpatient Center, Omaha, NE 68105 Phone: 402-559-5208 | |
John W Pflug, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 16929 Frances St, Suite 201 Omaha Ear, Nose & Throat Clinic, Omaha, NE 68130 Phone: 402-758-5330 Fax: 402-758-5339 | |
James V Huerter Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 17030 Lakeside Hills Plz, Suite 204, Omaha, NE 68130 Phone: 402-758-5600 Fax: 402-758-5169 |